Recurring concern

Medication quantity controls failing to prevent unsafe access to excessive amounts

Pin Get email alerts Request correction

First reported 14 Mar 2014•Latest report 27 Oct 2025

Definition

What this concern includes

Includes failures of controls dedicated to medication quantity governance, including prescribing, dispensing, online supply, transaction verification, ordering frequency, and adjustment of quantities to overdose or lethal-dose risk.

Not included

  • Excludes generic medication record-keeping failures unless they directly undermine medication quantity control.
  • Excludes medication counselling or clinical review failures when the report does not identify unsafe access to excessive quantities as the shared condition.
  • Excludes shortages, delays or insufficient access to medication.
  • Excludes unrelated failures in care, staffing, emergency response or other operational processes.
Reports
29

Distinct published reports

Individual concerns
33

A report can raise multiple concerns

Date range
2014–2025

First to latest report issue date

Stated actions
41

Described in published responses

Reports over time

Reports over time

Reports about this concern issued each year.

* 2026 is projected from reports observed to 7 Sep 2026.

Most frequent recipients

Most frequent recipients

Reports about this concern sent to each recipient.

Department of Health and Social Care5
NHS England4
Medicines and Healthcare products Regulatory Agency3
1st For Health International Limited1
Advisory Council on the Misuse of Drugs1
Axminster Medical Practice1
Bolton NHS Foundation Trust1
Cardiff & Vale University LHB1
Clinical Commissioning Group (Devon)1
c/o Mark Reynolds Solicitors1
Dartford and Gravesham NHS Trust1
Department for Digital, Culture, Media and Sport1
Devon Partnership NHS Trust1
Eltham Medical Practice1
General Medical Council1

Concerns and responses across reports

Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.

  1. Mid Kent and Medway

    AI-generated summary

    Natalie Mortimer · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Natalie Mortimer died on 21 April 2022 at St Thomas' Hospital after an overdose of colchicine tablets prescribed for gout. She developed multiorgan failure. Concerns included that information about a previous overdose was not added to her GP record and that 100 tablets were prescribed because this was the system default, without an alert identifying the previous overdose.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Reliance on default prescription quantities without adequate quantity validation

    Wider context from the report

    “(2) On the 25th November 2021 the patient attended the GP Practice and the GP on duty reviewed her most recent consultation which took place on the 22nd November 2021 and her records and prescribed the patient with ████████ to be taken 2-4 times a day until symptoms resolve for her gout. The GP detailed in evidence that she issued 100 tablets as this was the default quantity that came up on EMIS. The prescribing doctor stated that there were no alerts coding of a previous overdose in the patients records which may have been a contraindication for issuing a prescription of 100 tablets and therefore relied on the default quantity generated by the system. ”

    Source location

    Natalie Mortimer · Prevention of Future Deaths report
    Page 3 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Add colchicine safety alerts to patient records, recommending quantity limitation and risk assessment for patients with relevant mental-health histories.

    Verbatim wording from the response

    “6. We have put alerts on patient records for anyone requesting colchicine (see example enclosed) regarding the toxicity to ensure that this is explained to the patient at their next review. The alert recommends limiting the colchicine to 12 tablets and if there is a history of Mental health, depression, Suicide attempt or self-harm, to carry out a risk assessment before issuing.”

    Source location

    Response from Green Porch Medical Centre
    Page 2 · response
    Published 28 September 2022

    Open published response
  2. East London

    AI-generated summary

    Anita Mandalia · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Anita Mandalia took an overdose of prescribed medications at home on 7 February 2021 and died in hospital on 11 February 2021 from complications of the overdose. Concerns included prescribing beyond recommended guidance, failure to re-refer her to mental health services when concerns arose, and prescribing pain medication that gave her access to an excess of medication despite overdose-risk mitigation measures.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to maintain medication supplies within the maximum 7-day limit

    Wider context from the report

    “3. In June 2020 the surgery introduced measures to mitigate the risk of overdose presented by Mrs Mandalia which required medication to be dispensed in a dosette box containing a maximum 7-day supply of medications. However, on 6th January 2021 Mrs Mandalia was prescribed ████████████████████ for pain which allowed her access to an excess of a ████████ ”

    Source location

    Anita Mandalia · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report
  3. Black Country

    AI-generated summary

    Sarah Brady · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Sarah Brady, a 75-year-old woman, was admitted to hospital on 4 August 2020 after being found unresponsive at home following a presumed medication overdose. She deteriorated into multi-organ failure and died in hospital on 8 August 2020. The concerns included prescriptions exceeding the GP’s seven-day limit despite her history of overdose and erratic medication compliance, possible stockpiling of medication, and uncertainty about whether an additional hospital prescription had been fulfilled.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to limit prescription quantities and avoid duplicate prescribing for patients at high risk of medication overdose

    Wider context from the report

    “(2) Due to the above, Mrs Brady’s GP was only issuing 7 day prescriptions due to her high risk of overdose in order to limit medication availability. This included ████████ ████████ amongst others. (3) Mrs Brady had already been issued with a prescription by her GP on 14/7/20 for her regular prescription medication; (4) The inquest heard evidence that following a hospital admission in early July 2020, Mrs Brady was medically fit for discharge on 15/7/20 and a prescription was issued by the Sandwell & West Birmingham Hospital Trust for 14 days of ████████ ████████████████████████████████████████████████████████████████████████ ████████ (4) It was unclear from the evidence whether the prescription had actually been fulfilled by the hospital. I am concerned that Mrs Brady was issued with a prescription in excess of 7 days and for medication that had already been prescribed to her by her GP only the previous day and against a background of overdose and erratic compliance with her medications; (5) The levels of ████████ found as a result of qualitative testing appeared to be well in in excess of her prescriptions and there was evidence that Mrs Brady may have been stockpiling medication. It is possible that the additional prescription, if supplied may have formed part of the medication taken by way of overdose. (6) I heard at inquest that another similar prescription issued on 28/7/20 following a further admission had NOT been fulfilled. ”

    Source location

    Sarah Brady · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    The Trust disputes that Mrs Brady was oversupplied with medication, stating supplies were limited or not dispensed.

    Verbatim wording from the response

    “You will see from the attached list that, apart from the Aspirin, dispensed on 29 July 2020, medications were supplied for 7 days, 5 days or were not dispensed at all, instead giving back her own medications. The Aspirin was a new medication so was supplied to the level agreed with the CCG and in total only provided 2.1g, where the maximum daily dose for pain control is 4g.”

    Source location

    2021-0224-Response-from-Sandwell-General-Hospital-Redacted
    Page 1 · response
    Published 8 July 2021

    Open published response
  4. County Durham and Darlington

    AI-generated summary

    Claire RICHARDS · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Claire Richards had a history of drugs misuse and mental health issues and died at home after snorting illegally dealt pregabalin and buprenorphine, becoming unresponsive despite emergency services being summoned. The principal concern was the availability of prescription drugs in large quantities for illegal dealing to vulnerable people and the leakage of prescription medication from lawful dispensing into criminal hands.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Availability of prescription drugs in vast quantities for illegal dealing to vulnerable people

    Wider context from the report

    “(1) This case involves a death resulting from illegally dealt prescription drugs. It is of increasing concern that prescription drugs are available in vast quantities for illegal dealing to vulnerable people. ”

    Source location

    Claire RICHARDS · Prevention of Future Deaths report
    Page 1 · concerns

    Open source report

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    PHE and ACMD are the appropriate bodies to address concerns about prescription-drug misuse and medicine availability.

    Verbatim wording from the response

    “The report outlined matters of concern including the availability of prescription medicines to vulnerable people illegally, or outside of the healthcare system and controls on availability. For this reason we believe it would be appropriate for Public Health England (PHE) and the Advisory Council for the Misuse of Drugs (ACMD), who both have roles around the misuse of drugs to be aware of this report.”

    Source location

    2020-0253-Response-from-Royal-Pharmaceutical-Society-Redacted.pdf
    Page 1 · response
    Published 29 December 2020

    Open published response
  5. Suffolk

    AI-generated summary

    Gemma Louise Macdonald · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Gemma Louise Macdonald died on 22 July 2019 after taking a massive overdose of medication at home, including medicines purchased online. The report raised concerns about the availability of large quantities of medication online, whether purchaser suitability was assessed, and whether transactions were limited by quantity and ordering frequency.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Lack of a verification process limiting transaction amounts and ordering frequency

    Wider context from the report

    “(3) Whether there is verification process enabling the limiting of transactions to the amount of medicine and frequency of ordering ”

    Source location

    Gemma Louise Macdonald · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Availability of large quantities of medication for online purchase by an individual

    Wider context from the report

    “(1) The availability of large quantities of medication to purchase on online by an individual; ”

    Source location

    Gemma Louise Macdonald · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report
  6. Suffolk

    AI-generated summary

    Deborah Michelle HEADSPEATH · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Debbie Headspeath died suddenly at home on 28 July 2017 from aspiration pneumonitis caused by pancreatitis, which was linked in the report to long-term codeine use. The principal concerns were the lack of a central database for prescription-only medicines, uncoordinated access to codeine from multiple online suppliers, and the ability of some suppliers to operate outside the CQC regulatory regime.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to regulate online suppliers of prescription-only medication

    Wider context from the report

    “2. Evidence was heard from both the CQC and CQC registered on-line pharmacists of the changes that have been made to the way in which the prescription of opiate based medication (including codeine) is now conducted. CQC registered pharmacies should now not supply opiate based medications unless the patient provides permission for them to contact their registered GP. However, those suppliers who do not want to adhere to this requirement are simply changing their business model (primarily by only using prescribing doctors based overseas) and are relinquishing their CQC Regulated status. These prescribers are therefore still able to provide on-line prescription services (including opiate based medication) in the UK but now fall outside the CQC regulation regime. Clearly this is an area of concern as it will continue to allow patients to access uncoordinated quantities of prescription only medication from unregulated on-line suppliers. ”

    Source location

    Deborah Michelle HEADSPEATH · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to prevent uncoordinated quantities of prescription-only medication from online suppliers

    Wider context from the report

    “2. Evidence was heard from both the CQC and CQC registered on-line pharmacists of the changes that have been made to the way in which the prescription of opiate based medication (including codeine) is now conducted. CQC registered pharmacies should now not supply opiate based medications unless the patient provides permission for them to contact their registered GP. However, those suppliers who do not want to adhere to this requirement are simply changing their business model (primarily by only using prescribing doctors based overseas) and are relinquishing their CQC Regulated status. These prescribers are therefore still able to provide on-line prescription services (including opiate based medication) in the UK but now fall outside the CQC regulation regime. Clearly this is an area of concern as it will continue to allow patients to access uncoordinated quantities of prescription only medication from unregulated on-line suppliers. ”

    Source location

    Deborah Michelle HEADSPEATH · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Work with regulators to improve oversight of online prescribers and address legislative regulatory gaps.

    Verbatim wording from the response

    “The Department is working closely with the Care Quality Commission (CQC) and relevant professional regulators to look at how they can better regulate online prescribers and close the loopholes in legislation that allow a small number of online organisations to operate without the necessary oversight.”

    Source location

    2019-0387-Response-from-The-Department-of-Health-and-Social-Care
    Page 1 · response
    Published 27 December 2019

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Work with regulators to identify options for addressing online providers’ attempts to circumvent regulatory scrutiny.

    Verbatim wording from the response

    “In relation to your concern that online providers are changing their business model to circumvent regulatory scrutiny, the Department is working with the CQC and other regulators to understand what the options might be to address this.”

    Source location

    2019-0387-Response-from-The-Department-of-Health-and-Social-Care
    Page 3 · response
    Published 27 December 2019

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Oversight of online providers outside CQC regulation may fall to the General Pharmaceutical Council or Medicines and Healthcare products Regulatory Agency.

    Verbatim wording from the response

    “Where a provider is outside the scope of CQC regulation, oversight might fall to other regulators, namely the GPhC and the Medicines and Healthcare products Regulatory Agency (MHRA), and I am assured that all three regulators are working collaboratively to share information where there are concerns about a provider.”

    Source location

    2019-0387-Response-from-The-Department-of-Health-and-Social-Care
    Page 3 · response
    Published 27 December 2019

    Open published response
  7. South Wales Central

    AI-generated summary

    Mrs Ruth Ellen Edwards · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Mrs Ruth Ellen Edwards died at home on 31 August 2018 after hanging herself from an attic ladder, following a long history of mental health problems and previous suicide attempts. Concerns included her discharge after a drug overdose without psychiatric liaison assessment, inadequate risk assessment and inaccurate communication about the overdose, and potentially insufficient medication reviews despite access to many medications at home.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Availability of many boxes of different repeat-prescribed tablets posing an overdose risk

    Wider context from the report

    “(3) The GP practice may not have performed suitably frequent medication reviews with Mrs Edwards. Many boxes of different tablets were found at the family home, many on repeat prescription, posing an overdose risk. ”

    Source location

    Mrs Ruth Ellen Edwards · Prevention of Future Deaths report
    Page 1 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Employ a full-time clinical pharmacist to oversee and improve prescribing governance and patient monitoring.

    Verbatim wording from the response

    “Specifically with relation to the comments regarding medication reviews with ourselves as General Practitioners, we would recognise that this presents a particular challenge to us and safe prescribing of medicine requires a great deal of resource. In the last 12 months we have taken on a Clinical Pharmacist within the Practice Team on a full time basis whose responsibility it has been to oversee and improve the governance regarding repeat prescribing and acute prescribing of medications plus patient monitoring. We have in fact achieved an NHS award for quality improvement in this area and although this may have come too late for Mrs Edwards in order to reduce her risk, I would be confident that we have made great strides over and above that we would expect to meet standards of our General Practice.”

    Source location

    2018-0395-Response-by-West-Quay-Centre
    Page 1 · response
    Published 17 May 2019

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Raise medication-review frequency as a practice issue with the Primary, Community and Intermediate Care Clinical Board for consideration.

    Verbatim wording from the response

    “The GP practice may not have performed suitable frequent medication reviews with Mrs Edwards. Many boxes of different tablets were found at the family home. Many on repeat prescription posing an overdose risk.”

    Source location

    2018-0395-Response-by-University-Health-Board
    Page 3 · response
    Published 17 May 2019

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Medication review for patients managed in primary care is a matter for the GP practice and Primary, Community and Intermediate Care Clinical Board.

    Verbatim wording from the response

    “The GP practice may not have performed suitable frequent medication reviews with Mrs Edwards. Many boxes of different tablets were found at the family home. Many on repeat prescription posing an overdose risk.”

    Source location

    2018-0395-Response-by-University-Health-Board
    Page 3 · response
    Published 17 May 2019

    Open published response
  8. Manchester South

    AI-generated summary

    Karen Moran · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Karen Moran was found at home on 7 April 2018 and died after unsuccessful resuscitation attempts at Tameside General Hospital. Toxicology showed raised levels of prescribed dihydrocodeine and gabapentin, and the inquest heard that her recognised addiction to prescribed medication was not addressed through referral while repeat prescriptions continued to provide access to significant amounts of medication.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Prescribing patterns allowing access to significant amounts of prescribed medication

    Wider context from the report

    “She had a long term addiction to prescribed medication that had been recognised. Medication continued to be prescribed on repeat prescriptions with no referral to address the addiction. The prescribing pattern meant she had access to significant amounts of prescribed medication. ”

    Source location

    Karen Moran · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report
  9. London Inner South

    AI-generated summary

    Name not published · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    The deceased died at St Thomas’s Hospital on 22 November 2017 from brain damage sustained after he hanged himself at home on 20 November 2017. Concerns included changes and prescribing of psychiatric and sedative medication, inadequate clinical records and review of past records, failure to make an urgent psychiatric referral, and uncertainty about the medication found after his death and what he had taken.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Inappropriate prescribing of large medication quantities during an initial medication switch

    Wider context from the report

    “3. On 5 October 2017 the deceased saw Dr A again. The Zolpidem was swapped to Nitrazepam, a more potent sedative, as the deceased had said that after 2 weeks he had not found the Zolpidem to be effective. Expert evidence adduced at the inquest from ████████ was to the effect that the deceased’s presentation at this point should have triggered a further inquiry into his psychiatric history. ████████ said that he would have contacted the deceased’s home GP. 4. On 19 October 2017 the deceased saw Dr A again. He said he was feeling better on the Duloxetine but was still stressed and anxious and got a few anxiety attacks. Dr A prescribed him Propranolol, Nitrazepam and Xanax. Dr A also prescribed the deceased 6 months’ worth of Duloxetine. ████████ evidence was that it was “most unusual” to prescribe such a large amount of medication (6 months’ worth of Duloxetine) during the initial period where a patient’s medication had been switched and where close monitoring was needed. He opined that the first 6 weeks of the ‘switch’ period were ones in which the patient might get worse before getting better, might get worse and might develop suicidal thoughts. ████████ said that such a volume of medication was not merited clinically and could create a risk of overdose. 5. On 8 and 9 November 2017 the deceased saw Dr B. She made no notes of his presentation or diagnosis on any occasion when she saw him which she accepted she should have done. She also did not note her rationale for changing his medication which again ████████ said should have happened. He also considered that Dr B should have examined the past records for the deceased which she accepted she had not done in full. 6. There are a series of further issues with the medication Dr B prescribed the deceased and her records of the same. The electronic patient notes reflect a prescription for Xanax but she said in evidence that the deceased had not in fact accepted this. She prescribed him Temazepam but this is a controlled drug in this country and cannot be prescribed in the usual way. She changed this to Nitrazepam but the dose was incorrect and this was refused by the pharmacy. The next day she prescribed him Lorazepam without him returning the Nitrazepam prescription to her. She made an error in the dose for Lorazepam and had to correct that. When he attended on 15 November 2017 asking for more medication she made no note of his attendance. 7. ████████ evidence was that the multiple changes to the medication regime made by Dr B were not medically indicated and that the deceased had needed an urgent psychiatric referral. He said this was the case by 8 November 2017. 8. Overall ████████ said his impression was that Dr B did not understand what she was prescribing. 9. I accepted ████████ opinion on the various issues set out above. 10. Large numbers of boxes of medication were found at the deceased’s flat after his death by the police and his family. There remains some uncertainty as to where he obtained all the medication from, and what exactly he had taken and when. ”

    Source location

    Name not published · Prevention of Future Deaths report
    Page 1 · concerns

    Open source report
  10. Suffolk

    AI-generated summary

    Rachel Holly Edwards · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Rachel Holly Edwards died on 8 May 2017 after an overdose of multiple prescription medicines, following a period of severe and unbearable pain. Concerns identified at the inquest included unclear quantities of discharge medication, inadequate communication of prescriptions to her GP, record-keeping weaknesses, and the absence of a formal patient advocate system to support her when pain-management news and treatment administration increased her hopelessness.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to prescribe safe quantities of discharge medication for patients at risk of stockpiling medication

    Wider context from the report

    “The first concern regards the prescription of discharge medication, sharing that information with the GP and record keeping. It was known that Rachel was at risk of stockpiling medication as in the Serious Incident Requiring Investigation (SIRI) report it is noted that a request made on the 7th March 2017 by her treating doctor, for the disposal of her stocks of medication had not been actioned. Further, Rachel's care co-ordinator specifically recalled asking Rachel if she had stockpiled any medication after her discharge on the 29th March 2017, as he had identified this to be a risk. It is therefore a concern that according to Rachel's notes that on the day of her discharge she was supplied with 14 days of medication. This was described in evidence as ‘standard practice’. That said, some consideration appears to have been given to the quantity of some medication issued, as on closer inspection of the notes it was identified that specifically in relation to Tramadol Rachel had been prescribed this for only a 7-day period. However, there was no clear record within the notes if her other medication had actually been issued in 7 or 14 days amounts. Such confusion over the actual quantities of medication issued and the apparent issuing of 14 days supply of medicines to a patient who is known to have previously stockpiled medication, with a view to self-harm, is of obvious concern. Also of concern was evidence given by a senior consultant that there is no automated notification to a patient's GP of the type and amounts of prescription medicines issued to a patient upon discharge from Woodlands. Obviously, it is crucial that this information is readily available to a GP in all cases, to ensure that the over-prescription of medicines to a recently discharged patient does not occur. Evidence was heard that in order for Woodlands to notify a GP it is necessary for a staff member to e-mail the relevant practice, providing details of the prescriptions that had been made. This information would then have to be subsequently included in the patient's local record before it was available to the treating GP. Obviously, any system requiring such physical human input can be prone to failure and in the consultant's own words it was a recognised ‘point of weakness in the system’. ”

    Source location

    Rachel Holly Edwards · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Assess medications prescribed on discharge across the Trust.

    Verbatim wording from the response

    “The Trust will make an assessment of the medications prescribed upon discharge and this consideration will continue across the Trust. In the majority of situations an individual’s recovery into the community is supported by a period of care with the Crisis Resolution and Home Treatment team.”

    Source location

    Response from Norfolk and Suffolk NHS Foundation Trust
    Page 1 · response
    Published 30 April 2024

    Open published response
Back to top

Data last updated 7 September 2026